Cantel Medical Strikes Another Dental Deal

Cantel Medical Strikes Another Dental Deal

Cantel Medical Corp. (NYSE: CMD) acquired another medical device company last week, Hu-Friedy Mfg. Co., LLC. The target company has a long history as a dental instrument manufacturer, providing instrument reprocessing workflow systems that have served the dental industry for over 111 years. Cantel agreed to pay $725 million upfront, $60 million of which will be paid in Cantel stock and the rest in cash (3.x revenue and 15.1x EBITDA), and up to $50 million in potential cash and stock earnouts after reaching certain milestones. Combining Hu-Friedy’s position in dental instrumentation and instrument management systems with Cantel’s dental infection prevention consumables... Read More »
Smith & Nephew Acquires Robotics Firm Atracsys

Smith & Nephew Acquires Robotics Firm Atracsys

Smith & Nephew plc (NYSE: SNN) has been on a shopping spree this year. After reporting two deals in March and a third in April, they’re at it again. Now the medical device maker has acquired Atracsys Sarl, a Swiss medical device firm with a focus on robotics. The company provides optical navigation and robotic tracking components with applications in orthopedics, neurosurgery, spine and dental and other computer-assisted surgical procedures. Atracsys’ FusionTrack 500 optical tracking camera will be a core enabling technology for Smith & Nephew’s multi-asset digital surgery and robotic ecosystem. This transaction meshes well with a recent purchase in particular. No... Read More »
Cantel Medical Strikes Another Dental Deal

Varian Medical Makes Two Deals in May

Varian Medical Systems (NYSE: VAR) is on the move again. The Palo Alto, California-based medical device maker announced two deals in May 2019 targeting two very different companies. Varian (market cap $11.6 billion) designs, manufactures, sells and services medical devices and software products for treating cancer and other medical conditions. The earlier deal, announced on May 9, brought aboard privately held cardiac ablation firm Cyberheart, based in Sunnyvale, California, for an undisclosed amount. CyberHeart’s intellectual property covers cardiac radioablation, which involves using radiation in the heart and other forms of radiosurgery for certain heart diseases. The second deal,... Read More »
Advanced Wound Care Firm Acelity Grabbed for $6.7 Billion

Advanced Wound Care Firm Acelity Grabbed for $6.7 Billion

3m Company (NYSE: MMM), the global conglomerate, announced in early May it purchased Acelity Inc. for $6.7 billion, or roughly 11.4x EBITDA.  The target is a medical device consortium comprised of Apax Partners, affiliates of Canada Pension Plan Investment Board and the Public Sector Pension Investment Board, is selling Acelity. Acelity develops advanced wound care products and specialty surgical applications marketed under the KCI brand name. The company reported a revenue of $1.5 billion in 2018. This acquisition bolsters 3M’s Medical Solutions business and supports its growth strategy to offer comprehensive advanced and surgical wound care solutions. The transaction is expected to... Read More »
Orthopedic Device Companies Are all the Rage in 2019

Orthopedic Device Companies Are all the Rage in 2019

Stryker Corporation’s (NYSE: SYK) recently announced acquisition of OrthoSpace, Ltd., an Israeli based orthopedic company, for $110 million (with another $110 million in milestones), makes it tough to ignore 2019’s biggest trend in the medical device sector. Orthopedic companies, so far, have taken up nearly 40% of the medical device transactions this year. In the deal, Stryker gains OrthoSpace’s InSpace platform, a biodegradable sub-acromial spacer designed to realign the natural biomechanics of the shoulder. It expects the InSpace product will bolster its sports medicine portfolio in particular. The product has been used with 20,000 patients across 30 countries.... Read More »
Robotic Surgery Firm Auris Health Goes to Johnson & Johnson

Robotic Surgery Firm Auris Health Goes to Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) announced it will acquire Auris Health, Inc., a privately held developer of robotic technologies. J&J will pay $3.5 billion upfront and $2.35 billion in milestones under the terms of the agreement. This is J&J’s first acquisition in the medical device sector since 2016, when it bought Abbott Medical Optics from Abbott (NYSE: ABT). Auris Health’s technology focuses on lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. This acquisition will accelerate J&J’s entry into robotics with potential to expand into other interventional applications. Robotic technology deals... Read More »